Vaniprevir, Edoxaban Among Formal Japan Approvals
This article was originally published in PharmAsia News
Executive Summary
Japan has issued formal regulatory approvals to a group of products given positive recommendations over the past few weeks, including the first clearance worldwide to Merck & Co's hepatitis C drug vaniprevir.